Introduction
Unnecessary right ventricular (RV) pacing may cause cardiomyopathy in patients with preserved left ventricular systolic function 1 and increased morbidity and mortality in patients with reduced ejection fraction with implantable cardioverter-defibrillators. 2 The mechanisms of the detrimental effects of ventricular pacing remain incompletely understood. Ventricular pacing is known to produce both short and long term cardiac memory (CM) characterized by T-wave changes associated with altered activation sequence. 3 Recent studies have shown that ventricular pacing is associated with cytosolic calcium (Ca i ) accumulation at late activation sites. 4 The increased Ca i can cause significant changes of cardiac repolarization, including increased sodium-calcium exchange current (I NCX ) that tend to prolong the action potential duration (APD) and promote afterdepolarizations. 5 On the other hand, the increased Ca i could also activate apamin sensitive small conductance Ca 2+ activated K (SK) current (I KAS ), which helps to reduce the APD and preserve the repolarization reserve. 6 Because of the presence of these two opposing effects, ventricular pacing can cause transient APD prolongation at late activation sites leading to a positive APD-activation time (AT) relationship (short term CM) within 5-min of pacing. 7 Continued pacing for an hour or more can normalize the APD-AT relationship due to I KAS upregulation in late activation site. 6 Therefore, short term CM is transient and is well compensated by the upregulation of I KAS . However, the mechanism of long term CM remains unclear. We hypothesize that I KAS is upregulated at late activation sites during chronic ventricular pacing in rabbit ventricles but is of insufficient magnitude to suppress the manifestation of CM. Apamin, which blocks I KAS , aggravates APD prolongation at the late activation sites, reduces repolarization reserve and increases ventricular vulnerability to fibrillation. The purpose of the present study was to test these hypotheses.
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Methods
The study protocol was approved by the Institutional Animal Care and Use Committee of Indiana University School of Medicine and the Methodist Research Institute, Indianapolis, Indiana, and conformed to the regulations for humane care and treatment of animals established by the NIH. A total of 29 female New Zealand white rabbits (3.5-5.0 kg) were used in this study. Among them, 20 were used for chronically ventricular pacing and 9 normal rabbit hearts that were not paced were used as controls. A detailed methods section is included in the Online Supplement.
Pacing-Induced long-term CM and Optical Mapping
Ventricular epicardial pacing of either the right ventricle (n=9) or the left ventricle (n=11) was used to induce long-term CM. 8 Ventricles were paced at 270 beats per min (bpm) for 3-5
weeks. Each week, the T-wave from ECG Lead II was assessed. Chronic CM was defined by either a flat or inverted T-wave ( Figure 1 ). Echocardiography was performed both before the pacemaker implantation and at follow up. Optical mapping was performed on both paced hearts and normal hearts of both the RV and LV (Online Supplement Figure 1 ) as previously described. 
Protocol I -Electrophysiological Effects of Cardiac Memory
The CM model was created in 7 hearts with RV pacing and 3 hearts with LV pacing to determine if LV pacing showed the same characteristics as RV paced hearts. Five normal hearts were used as controls. The ventricular APD 80 was determined in each heart by pacing the right atrial appendage at 300 ms, and optical maps were acquired after at least 30 paced beats. To determine the role of I KAS , apamin (100 nmol/L) was then added to the perfusate and the protocol was repeated after 30 minutes. At that concentration, apamin is a highly specific I KAS blocker. 9 After radiofrequency ablation of the atrioventricular (AV) node, pacing was performed from the RV apex. A S1/S2/S3 (short/long/short) pacing protocol (S1 30 beats with S1-S1 300 ms, a long S1-S2 of 1000 ms or 2000ms and a S2-S3 starting from 300 ms and gradually shortened to the ventricular effective refractory period (ERP)) was used to simulate the ECG characteristics that initiates early after-depolarizations (EADs) and torsades de pointes (TdP) ventricular tachycardia in the clinical setting. 10 Finally, a dynamic ventricular pacing protocol was used to determine arrhythmia inducibility. If VF was not induced, burst pacing (PCL 50 ms, pacing duration 10 s) was used to induce VF. Any VF that occurred was allowed to continue for 180 s before a defibrillation attempt was made.
After the return to sinus rhythm, the heart was allowed to rest for 1 min before continuing the pacing protocol. VF induction was attempted 4 times in each heart. Phase singularities (PS) were used to quantify VF characteristics.
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Protocol II -Effects of Cardiac Memory on Arrhythmia Inducibility
In protocol I, all arrhythmia inducibility data was acquired after apamin infusion. To determine the effects of CM on arrhythmia inducibility and the role of I KAS , 3 additional hearts with chronic LV pacing were used to acquire data on ventricular stability at baseline and after
apamin infusion. In each heart, AV nodal ablation was performed, and to determine the inducibility of any EADs and VF, ventricular pacing was performed as described in protocol I.
Any ventricular arrhythmias that resulted from the pacing were noted and then apamin (100 nmol/L) was added to the perfusate and the protocol was repeated after 30 min.
Western Blotting
Among the 3 different subtypes of SK channels, SK2 is known to be the most sensitive to apamin and contribute the most to I KAS . 12 To determine the protein expression of SK2 channels within the myocardial tissue, Western blotting was performed on tissue acquired from sites distal and proximal to the chronic pacing site in 4 chronically paced hearts and from similar areas in 4 normal hearts.
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Histology
For histology, ventricular tissue from 4 normal hearts and 4 chronically paced hearts was embedded in paraffin, sectioned and stained using Masson's trichrome stain. The collagen content was quantified by identifying and counting the number of blue-staining pixels as a percentage of the total tissue area using digital photomicrographs in Adobe Photoshop CS6
software.
Quantitative PCR
Quantitive polymerase chain reaction (PCR) was used to determine the expression of transcripts encoding kcnn2 (SK2) and kcnn3 (SK3) in tissue acquired from sites distal and proximal to the chronic pacing site in 3 chronically paced hearts.
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Statistical Analysis
Data are presented as mean and 95% confidence interval (CI). Paired Student t tests were used to compare variables measured at baseline and after apamin infusion. An independent-sample t test was used to compare variables measured between groups. A one way ANOVA was used to compare SK2 protein expression between different groups, and a paired t-test was used to compared RNA levels between the proximal and distal sites.
Categorical parameters between groups comparing VF vulnerability were compared by either a chi-square test or the Fisher exact test. A 2-sided P value of ≤0.05 was considered statistically significant.
Results
All rabbits survived the chronic pacing protocol. Long term CM was assessed by T-wave changes in the ECG (flat or inverted T-wave after pacing). As shown in Figure 1 , after 28 days of ventricular pacing, the ECG shows a T-wave that changed to flat or inverted in both RV and LV paced hearts. There were no significant differences in echocardiographic based Figure 2D ), with no differences between RV and LV paced ventricles.
APD heterogeneity has been shown to be an important factor that contributes to increased vulnerability to ventricular arrhythmias. 14 Figure 2C shows that after apamin the standard deviation (SD) of APD 80 significantly increased at 300 PCL in CM hearts, but not in normal hearts. 
Characteristics of Ca
Chronic ventricular pacing is proarrhythmic
In protocol I, a dynamic ventricular pacing protocol was used to determine arrhythmia inducibility between normal and paced hearts. For all hearts studied, after apamin, paced ventricles developed APD alternans ( Figure 5A ) at a longer PCL than the control group (Fig 5D) .
In protocol II, 3 additional hearts were studied to investigate ventricular vulnerability to fibrillation at baseline and after apamin infusion. Figure 6A shows representative examples of optical mapping traces at baseline and after addition of apamin demonstrating a significant prolongation of the APD 80 at a PCL of 1000 ms after apamin infusion. At baseline, only one of the three paced hearts developed a TdP arrhythmia. However, after apamin infusion, all of the three paced hearts developed a TdP arrhythmia during short-long-short pacing. An example of TdP induced with short-long-short pacing is shown in Figure 6B . In addition, the site of earliest activation of the TdP occurred at the sites farthest from the chronic pacing site ( Figure 6C ). In these 3 CM hearts, there were 5 VF episodes at baseline and 11 episodes after apamin infusion. Examples of phase maps during VF with marked phase singularities (black arrows) at baseline and after apamin infusion is shown in Figure 7A and 7B. Figure 7C summarizes the number of phase singularities in all hearts studied in Protocol II. There was a significant increase of phase singularities after apamin.
SK2 Protein and RNA Expression
Western blotting was performed in 4 normal hearts and 4 chronically paced hearts (2 RV pacing and 2 LV pacing). As the results in Figure 8 show, there was no significant difference in the SK2 protein expression between normal and chronically paced hearts. However, qPCR analysis showed that there was a significant increase in both SK2 (0. 
I KAS blockade and ventricular vulnerability to fibrillation
In paced ventricles, inhibiting I KAS increased VF vulnerability and the incidence of TdP induced with EADs. These data support that I KAS plays a significant compensatory role in CM and protects against arrhythmia initiation. Several commonly used drugs, including amiodarone 15 and ondansetron, 16 are known to block I KAS . Whether or not I KAS inhibition increases arrhythmia risk for pacemaker patients deserves further investigation.
Mechanisms of cardiac memory
CM is characterized by a change in T-wave morphology resulting from either M A N U S C R I P T
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13 electrophysiological or structural remodeling induced by either ventricular pacing or myocardial stretch. 17, 18 Varying degrees of CM has been shown after minutes to hours of pacing (producing "short-term" CM) and after 2 to 5 weeks of pacing ("long-term" CM). Two weeks of pacing is required to achieve a steady-state change in the T-wave. Molecular mechanisms of CM have been extensively reviewed recently. 19, 20 Short-term CM that is observed within minutes of ventricular pacing is thought to occur from modulation and modification of angiotensin II which has been shown to regulate I to . Long-term CM, seen after longer periods of ventricular pacing and is longer lasting (days to weeks), includes alterations in AT1 receptors, stretch-activated receptors, 21, 22 connexins 23, 24 and in ion channels specifically I to , I kr , and I Ca,L which results in an altered repolarization gradient. The mechanisms underlying this ion channel remodeling revolves around changes in gene transcription and protein synthesis. 19, 20 This study is the first to show that in addition to the currents mentioned above, I KAS may also play a role in long-term CM.
Clinical Implications
This study provided new insights into the mechanisms of CM. The importance of I KAS in human ventricular repolarization is supported by a previous study that showed apamin prolonged the APD in the failing human ventricular myocardium. 25 In CM models, we have observed an increased APD heterogeneity, steepened maximal slope of APDR, increased PCL threshold for alternans and increased spatially discordant APD alternans after I KAS inhibition, factors which increase vulnerability to ventricular arrhythmias. These findings suggest drugs that block I KAS may be unsafe for patients with chronic ventricular pacing. A second clinical implication is that I KAS upregulation helps to shorten the APD 80 and counteract M A N U S C R I P T
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Study Limitations
We only studied the acute effects of apamin in an ex vivo perfused heart model. We did not investigate the chronic administration of a SK channel blocker in an ambulatory cardiac memory model. In addition, we did not investigate SK1 or SK3 protein levels as a reliable antibody is not available for rabbit hearts.
Conclusions
Chronic ventricular pacing increases Ca i at late activation sites which helps to activate I KAS to shorten the APD and maintain repolarization reserve. Inhibiting I KAS significantly lengthens the APD at late activation sites and increases VF vulnerability. I KAS blockade may contribute to the underlying mechanism of sudden cardiac death in patients with permanent ventricular pacing.
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